| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.83 | 0.0008 |